Surgery Websites
Transplant Surgery »  Meet the Team »  Nephrology »  Sindhu Chandran, M.D.
Sindhu Chandran, M.D.

Sindhu Chandran, M.D.

Associate Professor of Medicine
Division of Nephrology
Department of Medicine

Open Popup

All India Institute of Medical Sciences, M.B., B.S., 2001

  • University of Arizona, Intern, Medicine, 2004-2005
  • University of Arizona, Resident, Medicine, 2005-2007
  • Stanford University, Fellow, Medicine, 2007-2010
  • University of California, San Francisco, Fellow, Medicine, 2010-2011
  • American Board of Internal Medicine, Internal Medicine
  • American Board of Internal Medicine, Nephrology Subspecialty
  • Chronic Kidney Disease
  • Immunosuppression for Kidney Transplantation
  • Kidney Transplantation
  • Living Kidney Donor Transplantation
  • Transplant Nephrology
  • Kidney Allocation
  • New-onset Diabetes After Transplantation (NODAT)
  • Protocol Kidney Biopsies

Dr. Chandran is an Assistant Professor at UCSF in the Department of Medicine, Division of Nephrology. A kidney and pancreas transplant specialist, Dr. Chandran is board certified in internal medicine and nephrology. She earned her medical degree at All India Institute of Medical Sciences, and completed her residency at the University of Arizona, a nephrology fellowship at Stanford University, and a Transplant Nephrology Fellowship at UCSF.  

Data provided by UCSF Profiles, powered by CTSI
ORCID iD: 0000-0003-4547-3381 Additional info
  • Applying precision MEdicine to optimize desensitization with noveL bIOlogics or cellular theRApies in highly sensiTized kidney transplant patiEnts (AMELIORATE)
    Sponsor:
    Sponsor ID:
    Funding Period:
    Jul 2014
    -
    May 2024
    Co-Investigator
  • Novel Therapies to Modulate the Inflammatory Alloresponse in Renal Grafts
    Sponsor:
    Sponsor ID:
    Funding Period:
    Jul 2014
    -
    Jun 2021
    Co-Investigator
Data provided by UCSF Profiles, powered by CTSI
MOST RECENT PUBLICATIONS FROM A TOTAL OF 54
Data provided by UCSF Profiles, powered by CTSI
  1. Zarinsefat A, Hartoularos G, Rychkov D, Rashmi P, Chandran S, Vincenti F, Yee CJ, Sarwal MM. Single-Cell RNA Sequencing of Tocilizumab-Treated Peripheral Blood Mononuclear Cells as an in vitro Model of Inflammation. Front Genet. 2020; 11:610682. View in PubMed
  2. Chandran S, Leung J, Hu C, Laszik ZG, Tang Q, Vincenti FG. Interleukin-6 blockade with tocilizumab increases Tregs and reduces T effector cytokines in renal graft inflammation: A randomized controlled trial. Am J Transplant. 2021 07; 21(7):2543-2554. View in PubMed
  3. Chandran S, Wojciechowski D. Converting Maintenance Kidney-Transplant Patients From Belatacept to Another Immunosuppressive Regimen: A Cautionary Tale. Kidney Int Rep. 2020 Dec; 5(12):2123-2124. View in PubMed
  4. Sindhu Chandran, David Wojciechowski. Converting maintenance kidney-transplant patients from belatacept to another immunosuppressive regimen: A Cautionary Tale. Kidney International Reports. 2020 Nov 1. View in PubMed
  5. Fung M, Nambiar A, Pandey S, Aldrich JM, Teraoka J, Freise C, Roberts J, Chandran S, Hays SR, Bainbridge E, DeVoe C, Roque Gardner A, Yokoe D, Henrich TJ, Babik JM, Chin-Hong P. Treatment of immunocompromised COVID-19 patients with convalescent plasma. Transpl Infect Dis. 2021 Apr; 23(2):e13477. View in PubMed
  6. View All Publications
Data provided by UCSF Profiles, powered by CTSI

 

Site Directory
    X